124 related articles for article (PubMed ID: 36702715)
1. Disappearing colorectal liver metastases in the era of state-of-the-art triple-modality diagnostic imaging.
Kuhlmann KF; Tufo A; Kok NF; Gordon-Weeks A; Poston GJ; Diaz Nieto R; Jones R; Fenwick SW; Malik HZ
Eur J Surg Oncol; 2023 May; 49(5):1016-1022. PubMed ID: 36702715
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications of disappearing colorectal liver metastases have changed in the era of hepatocyte-specific MRI and contrast-enhanced intraoperative ultrasonography.
Oba A; Mise Y; Ito H; Hiratsuka M; Inoue Y; Ishizawa T; Arita J; Matsueda K; Takahashi Y; Saiura A
HPB (Oxford); 2018 Aug; 20(8):708-714. PubMed ID: 29534862
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of contrast-enhanced intraoperative ultrasound in identifying disappearing liver metastases from colorectal carcinoma after chemotherapy.
Arita J; Ono Y; Takahashi M; Inoue Y; Takahashi Y; Saiura A
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S390-7. PubMed ID: 24570378
[TBL] [Abstract][Full Text] [Related]
4. Management of disappearing lesions after chemotherapy for colorectal liver metastases: Relation between detectability and residual tumors.
Tani K; Shindoh J; Akamatsu N; Arita J; Kaneko J; Sakamoto Y; Hasegawa K; Kokudo N
J Surg Oncol; 2018 Feb; 117(2):191-197. PubMed ID: 28876456
[TBL] [Abstract][Full Text] [Related]
5. Colorectal liver metastases: disappearing lesions in the era of Eovist hepatobiliary magnetic resonance imaging.
Owen JW; Fowler KJ; Doyle MB; Saad NE; Linehan DC; Chapman WC
HPB (Oxford); 2016 Mar; 18(3):296-303. PubMed ID: 27017170
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment.
Niekel MC; Bipat S; Stoker J
Radiology; 2010 Dec; 257(3):674-84. PubMed ID: 20829538
[TBL] [Abstract][Full Text] [Related]
7. Utility of Image Guidance in the Localization of Disappearing Colorectal Liver Metastases.
Pak LM; Gagnière J; Allen PJ; Balachandran VP; D'Angelica MI; DeMatteo RP; Jarnagin WR; Miga MI; Simpson AL; Kingham TP
J Gastrointest Surg; 2019 Apr; 23(4):760-767. PubMed ID: 30680630
[TBL] [Abstract][Full Text] [Related]
8. Colorectal liver metastases: CT, MR imaging, and PET for diagnosis--meta-analysis.
Bipat S; van Leeuwen MS; Comans EF; Pijl ME; Bossuyt PM; Zwinderman AH; Stoker J
Radiology; 2005 Oct; 237(1):123-31. PubMed ID: 16100087
[TBL] [Abstract][Full Text] [Related]
9. Predictors of a true complete response among disappearing liver metastases from colorectal cancer after chemotherapy.
Auer RC; White RR; Kemeny NE; Schwartz LH; Shia J; Blumgart LH; Dematteo RP; Fong Y; Jarnagin WR; D'Angelica MI
Cancer; 2010 Mar; 116(6):1502-9. PubMed ID: 20120032
[TBL] [Abstract][Full Text] [Related]
10. Management of disappearing colorectal liver metastases.
Kuhlmann K; van Hilst J; Fisher S; Poston G
Eur J Surg Oncol; 2016 Dec; 42(12):1798-1805. PubMed ID: 27260846
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of CE-CT, MRI and FDG PET/CT for detecting colorectal cancer liver metastases in patients considered eligible for hepatic resection and/or local ablation.
Sivesgaard K; Larsen LP; Sørensen M; Kramer S; Schlander S; Amanavicius N; Bharadwaz A; Tønner Nielsen D; Viborg Mortensen F; Morre Pedersen E
Eur Radiol; 2018 Nov; 28(11):4735-4747. PubMed ID: 29736846
[TBL] [Abstract][Full Text] [Related]
12. Colorectal Cancer Liver Metastases: Diagnostic Performance and Prognostic Value of PET/MR Imaging.
Lee DH; Lee JM; Hur BY; Joo I; Yi NJ; Suh KS; Kang KW; Han JK
Radiology; 2016 Sep; 280(3):782-92. PubMed ID: 27092659
[TBL] [Abstract][Full Text] [Related]
13. Assessment of local control after laser-induced thermotherapy of liver metastases from colorectal cancer: contribution of FDG-PET in patients with clinical suspicion of progressive disease.
Denecke T; Steffen I; Hildebrandt B; Rühl R; Streitparth F; Lehmkuhl L; Langrehr J; Ricke J; Amthauer H; Hänninen EL
Acta Radiol; 2007 Oct; 48(8):821-30. PubMed ID: 17924212
[TBL] [Abstract][Full Text] [Related]
14. Controversies in the management of colorectal liver metastases: role of PET and PET/CT.
Wiering B; Vogel WV; Ruers TJ; Oyen WJ
Dig Surg; 2008; 25(6):413-20. PubMed ID: 19212113
[TBL] [Abstract][Full Text] [Related]
15. Preoperative imaging of colorectal liver metastases after neoadjuvant chemotherapy: a meta-analysis.
van Kessel CS; Buckens CF; van den Bosch MA; van Leeuwen MS; van Hillegersberg R; Verkooijen HM
Ann Surg Oncol; 2012 Sep; 19(9):2805-13. PubMed ID: 22396005
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic performance of MDCT, PET/CT and gadoxetic acid (Primovist(®))-enhanced MRI in patients with colorectal liver metastases being considered for hepatic resection: initial experience in a single centre.
Chan VO; Das JP; Gerstenmaier JF; Geoghegan J; Gibney RG; Collins CD; Skehan SJ; Malone DE
Ir J Med Sci; 2012 Dec; 181(4):499-509. PubMed ID: 22426901
[TBL] [Abstract][Full Text] [Related]
17. Utility of 18F-FDG PET and contrast-enhanced CT scan in the assessment of residual liver metastasis from colorectal cancer following adjuvant chemotherapy.
Carnaghi C; Tronconi MC; Rimassa L; Tondulli L; Zuradelli M; Rodari M; Doci R; Luttmann F; Torzilli G; Rubello D; Al-Nahhas A; Santoro A; Chiti A
Nucl Med Rev Cent East Eur; 2007; 10(1):12-5. PubMed ID: 17694495
[TBL] [Abstract][Full Text] [Related]
18. The role of whole-body positron emission tomography with [18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver.
Lai DT; Fulham M; Stephen MS; Chu KM; Solomon M; Thompson JF; Sheldon DM; Storey DW
Arch Surg; 1996 Jul; 131(7):703-7. PubMed ID: 8678767
[TBL] [Abstract][Full Text] [Related]
19. [Recurrance of disappearing colorectal liver metastases after mFOLFOX6 regimen].
Ono T; Okada N; Kumamoto K; Ishibashi K; Haga N; Ishida H
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2214-5. PubMed ID: 22202334
[TBL] [Abstract][Full Text] [Related]
20. Disappearing liver metastases: A systematic review of the current evidence.
Tsilimigras DI; Ntanasis-Stathopoulos I; Paredes AZ; Moris D; Gavriatopoulou M; Cloyd JM; Pawlik TM
Surg Oncol; 2019 Jun; 29():7-13. PubMed ID: 31196496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
